Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study
In this cohort study, rivaroxaban was found to be significantly more effective than enoxaparin in reducing postoperative VTE after hip fracture, but it was associated with a higher risk of hemorrhagic events. Additionally, the average daily cost of rivaroxaban was lower. To identify patients who will derive the maximum advantages from this treatment, larger prospective studies are needed.
Authors
- Cong Xiao (ORCID: https://orcid.org/0000-0002-2374-8738)
- Zhaoqiang Zhang (ORCID: https://orcid.org/0000-0002-9183-7273)
- Lijuan Liu (ORCID: https://orcid.org/0000-0001-8068-8498)
- Xiaofeng Zheng (ORCID: https://orcid.org/0009-0008-4250-1598)
- Lifu Wang (ORCID: https://orcid.org/0000-0001-5172-9932)
- Yinhua Chen (ORCID: https://orcid.org/0000-0003-2481-1054)
Institutions
- Mianyang Third People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Surgery
- Published
- 2025-05-09
- DOI
- https://doi.org/10.3389/fsurg.2025.1483611
- Citations
- 2
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.74